These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25262260)

  • 1. Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
    Bagai A; Schulte PJ; Granger CB; Mahaffey KW; Christenson RH; Bell G; Lopes RD; Green CL; Lincoff AM; Armstrong PW; Roe MT
    Am Heart J; 2014 Oct; 168(4):503-511.e2. PubMed ID: 25262260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Nienhuis MB; Ottervanger JP; de Boer MJ; Dambrink JH; Hoorntje JC; Gosselink AT; Suryapranata H; van't Hof AW;
    Am Heart J; 2008 Apr; 155(4):673-9. PubMed ID: 18371475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.
    Leonardi S; Thomas L; Neely ML; Tricoci P; Lopes RD; White HD; Armstrong PW; Giugliano RP; Antman EM; Califf RM; Newby LK; Mahaffey KW
    J Am Coll Cardiol; 2012 Dec; 60(22):2296-304. PubMed ID: 23122801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
    Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of creatine kinase-myocardial band isoenzyme elevation following percutaneous coronary intervention: a meta-analysis.
    Jang JS; Jin HY; Seo JS; Yang TH; Kim DK; Kim DS; Cho KI; Kim BH; Je HG; Park YH
    Catheter Cardiovasc Interv; 2013 May; 81(6):959-67. PubMed ID: 22744792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapy.
    Lopes RD; Lokhnygina Y; Hasselblad V; Newby KL; Yow E; Granger CB; Armstrong PW; Hochman JS; Mills JS; Ruzyllo W; Mahaffey KW
    Trials; 2013 May; 14():123. PubMed ID: 23782531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
    Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern of liver enzyme elevations in acute ST-elevation myocardial infarction.
    Lofthus DM; Stevens SR; Armstrong PW; Granger CB; Mahaffey KW
    Coron Artery Dis; 2012 Jan; 23(1):22-30. PubMed ID: 22113063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Ndrepepa G; Colleran R; Braun S; Xhepa E; Hieber J; Cassese S; Fusaro M; Kufner S; Laugwitz KL; Schunkert H; Kastrati A
    Catheter Cardiovasc Interv; 2018 Feb; 91(2):215-223. PubMed ID: 28500730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction.
    Mills JS; Mahaffey KW; Lokhnygina Y; Nicolau JC; Ruzyllo W; Adams PX; Todaro TG; Armstrong PW; Granger CB;
    Coron Artery Dis; 2012 Mar; 23(2):118-25. PubMed ID: 22217457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Identification and diagnosis of myocardial damage and acute myocardial infarction during cardiopulmonary resuscitation].
    Wang JG; Kong DQ; Huang Y; Huang JY; Zhang ZL; Wu WC; Pan XW
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jun; 21(6):333-6. PubMed ID: 19570336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.
    Lindsey JB; Marso SP; Pencina M; Stolker JM; Kennedy KF; Rihal C; Barsness G; Piana RN; Goldberg SL; Cutlip DE; Kleiman NS; Cohen DJ;
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1074-82. PubMed ID: 19926047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant Association of Serum Adiponectin and Creatine Kinase-MB Levels in ST-Segment Elevation Myocardial Infarction.
    Natsukawa T; Maeda N; Fukuda S; Yamaoka M; Fujishima Y; Nagao H; Sato F; Nishizawa H; Sawano H; Hayashi Y; Funahashi T; Kai T; Shimomura I
    J Atheroscler Thromb; 2017 Aug; 24(8):793-803. PubMed ID: 28100880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Chia S; Senatore F; Raffel OC; Lee H; Wackers FJ; Jang IK
    JACC Cardiovasc Interv; 2008 Aug; 1(4):415-23. PubMed ID: 19463339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of intra-aortic balloon pump support initiated before versus after primary percutaneous coronary intervention in patients with cardiogenic shock from acute myocardial infarction.
    Cheng JM; van Leeuwen MA; de Boer SP; Wai MC; den Uil CA; Jewbali LS; van Geuns RJ; Kardys I; van Domburg RT; Boersma E; Zijlstra F; Akkerhuis KM
    Int J Cardiol; 2013 Oct; 168(4):3758-63. PubMed ID: 23830073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry.
    Lindsey JB; Kennedy KF; Stolker JM; Gilchrist IC; Mukherjee D; Marso SP; Pencina MJ; Kleiman NS; Cohen DJ
    Circ Cardiovasc Interv; 2011 Oct; 4(5):474-80. PubMed ID: 21972402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome c release in acute myocardial infarction predicts poor prognosis and myocardial reperfusion on contrast-enhanced magnetic resonance imaging.
    Liu ZB; Fu XH; Wei G; Gao JL
    Coron Artery Dis; 2014 Jan; 25(1):66-72. PubMed ID: 24077325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study.
    Bagai A; Armstrong PW; Stebbins A; Mahaffey KW; Hochman JS; Weaver WD; Patel MR; Granger CB; Lopes RD
    Am Heart J; 2013 Nov; 166(5):913-9. PubMed ID: 24176448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Pride YB; Appelbaum E; Lord EE; Sloan S; Cannon CP; Sabatine MS; Gibson CM;
    Am J Cardiol; 2009 Aug; 104(4):475-9. PubMed ID: 19660597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.